| Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma P Nghiem, S Bhatia, EJ Lipson, WH Sharfman, RR Kudchadkar, AS Brohl, ... Journal for immunotherapy of cancer 9 (4), 2021 | 91 | 2021 |
| Immune checkpoint inhibitors to treat cutaneous malignancies DM Barrios, MH Do, GS Phillips, MA Postow, T Akaike, P Nghiem, ... Journal of the American Academy of Dermatology 83 (5), 1239-1253, 2020 | 80 | 2020 |
| High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma T Akaike, J Qazi, A Anderson, FS Behnia, MM Shinohara, G Akaike, ... British Journal of Dermatology 184 (2), 319-327, 2021 | 41 | 2021 |
| How we treat Merkel cell carcinoma: within and beyond current guidelines SY Park, C Doolittle-Amieva, Y Moshiri, T Akaike, U Parvathaneni, ... Future Oncology 17 (11), 1363-1377, 2021 | 30 | 2021 |
| Imaging of Merkel cell carcinoma: what imaging experts should know G Akaike, T Akaike, SA Fadl, K Lachance, P Nghiem, F Behnia Radiographics 39 (7), 2069-2084, 2019 | 30 | 2019 |
| Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer T Akaike, P Nghiem Journal of dermatological science 105 (1), 2-10, 2022 | 13 | 2022 |
| The relationship between circulating tumor DNA with Merkel cell carcinoma tumor burden and detection of recurrence. T Akaike, N So, DS Hippe, L Gunnell, C Doolittle-Amieva, K Lachance, ... Journal of Clinical Oncology 40 (16_suppl), 9566-9566, 2022 | 8 | 2022 |
| 590 detecting Merkel cell carcinoma recurrence using a blood test: outcomes from 774 patients K Lachance, T Akaike, K Cahill, L Zawacki, N Singh, C Doolittle-Amieva, ... Journal of Investigative Dermatology 139 (5), S101, 2019 | 8 | 2019 |
| The evolving treatment landscape of Merkel cell carcinoma N Singh, EM McClure, T Akaike, SY Park, ET Huynh, PH Goff, P Nghiem Current Treatment Options in Oncology 24 (9), 1231-1258, 2023 | 7 | 2023 |
| Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review T Akaike, K Cahill, G Akaike, ET Huynh, DS Hippe, MM Shinohara, J Liao, ... Cancers 14 (23), 5914, 2022 | 2 | 2022 |
| 1545 Circulating tumor DNA reflects tumor burden and detects early recurrence in patients with Merkel cell carcinoma T Akaike, DS Hippe, N So, N Maloney, L Gunnell, E Hall, A Rodriguez, ... Journal of Investigative Dermatology 143 (5), S265, 2023 | 1 | 2023 |
| Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy LM Tachiki, L Zawacki, DS Hippe, Y Moshiri, N Alexander, T Akaike, ... Journal of Investigative Dermatology 142 (10), 2840, 2022 | 1 | 2022 |
| 292 Is it safe to discontinue immunotherapy after a response in Merkel cell carcinoma? L Tachiki, L Zawacki, D Hippe, Y Moshiri, N Alexander, T Akaike, ... Journal of Investigative Dermatology 142 (8), S50, 2022 | 1 | 2022 |
| Merkel cell carcinoma can be indolent: A case with 7 locoregional recurrences over 15 years highlights the importance of patient-tailored management A Breneman, T Akaike, KG Paulson, DL Breneman, P Nghiem JAAD Case Reports 16, 58-61, 2021 | 1 | 2021 |
| 675 Utility of circulating tumor DNA testing in Merkel cell carcinoma patients T Akaike, C Doolittle-Amieva, K Lachance, AS Fonseca, C Church, E Hall, ... Journal of Investigative Dermatology 141 (5), S117, 2021 | 1 | 2021 |
| 497 Efficacy of immunotherapy in Merkel cell carcinoma patients with chronic immunosuppression L Zawacki, K Lachance, T Akaike, P Nghiem Journal of Investigative Dermatology 140 (7), S67, 2020 | 1 | 2020 |
| LB914 A single postoperative dose of radiotherapy (8 Gy) has comparable efficacy to a standard 5-week course for localized Merkel cell carcinoma (MCC) ET Huynh, PH Goff, DS Hippe, X Fan, A Menon, K Biese, N Harikrishnan, ... Journal of Investigative Dermatology 144 (8), S160, 2024 | | 2024 |
| 113 Outcomes among 31 Merkel cell carcinoma patients with positive circulating tumor DNA but no clinically evident disease AJ Jabbour, A Finberg, A Fu, R Alam, K Biese, T Akaike, K Lachance, ... Journal of Investigative Dermatology 144 (8), S20, 2024 | | 2024 |
| Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications T Akaike, M Thakuria, AW Silk, DS Hippe, SY Park, NA So, NJ Maloney, ... Journal of Clinical Oncology, JCO. 23.02054, 2024 | | 2024 |
| Merkel cell carcinoma refractory to anti-PD (L) 1: utility of adding ipilimumab for salvage therapy T Akaike, AJ Jabbour, PH Goff, SY Park, S Bhatia, P Nghiem Journal for Immunotherapy of Cancer 12 (7), 2024 | | 2024 |
Paul NghiemUniversity of Washington; Fred Hutchinson Cancer Center在 uw.edu 的电子邮件经过验证
